

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin filament-based movement (GO:0030048) | 9.65197494 |
| 2 | regulation of skeletal muscle contraction (GO:0014819) | 9.47437585 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 8.43060125 |
| 4 | plasma membrane repair (GO:0001778) | 7.68415699 |
| 5 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.09488817 |
| 6 | striated muscle contraction (GO:0006941) | 6.81275657 |
| 7 | myofibril assembly (GO:0030239) | 5.85722618 |
| 8 | response to muscle activity (GO:0014850) | 5.66296097 |
| 9 | sarcomere organization (GO:0045214) | 5.37476003 |
| 10 | skeletal muscle fiber development (GO:0048741) | 5.19203306 |
| 11 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.10724921 |
| 12 | myotube cell development (GO:0014904) | 5.09337890 |
| 13 | negative regulation of protein localization to cell surface (GO:2000009) | 4.97779853 |
| 14 | regulation of cell communication by electrical coupling (GO:0010649) | 4.95537674 |
| 15 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.83491026 |
| 16 | muscle contraction (GO:0006936) | 4.78961473 |
| 17 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.76818980 |
| 18 | skeletal muscle adaptation (GO:0043501) | 4.66062011 |
| 19 | muscle cell fate commitment (GO:0042693) | 4.47578821 |
| 20 | cardiac myofibril assembly (GO:0055003) | 4.40548713 |
| 21 | negative regulation of fatty acid transport (GO:2000192) | 4.33359336 |
| 22 | actomyosin structure organization (GO:0031032) | 4.20179456 |
| 23 | muscle system process (GO:0003012) | 4.15886136 |
| 24 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 4.15725203 |
| 25 | regulation of calcium ion transmembrane transport (GO:1903169) | 4.15725203 |
| 26 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 4.12814425 |
| 27 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 4.12814425 |
| 28 | positive regulation of myoblast differentiation (GO:0045663) | 4.12537305 |
| 29 | skeletal muscle tissue regeneration (GO:0043403) | 4.12166332 |
| 30 | positive regulation of fatty acid oxidation (GO:0046321) | 4.06450320 |
| 31 | cytidine metabolic process (GO:0046087) | 4.01289658 |
| 32 | cytidine catabolic process (GO:0006216) | 4.01289658 |
| 33 | cytidine deamination (GO:0009972) | 4.01289658 |
| 34 | creatine metabolic process (GO:0006600) | 4.01032452 |
| 35 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.98405919 |
| 36 | regulation of sarcomere organization (GO:0060297) | 3.97324987 |
| 37 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.92802379 |
| 38 | muscle fiber development (GO:0048747) | 3.81238779 |
| 39 | muscle organ development (GO:0007517) | 3.77759141 |
| 40 | muscle cell cellular homeostasis (GO:0046716) | 3.77191670 |
| 41 | regulation of actin filament-based movement (GO:1903115) | 3.76710101 |
| 42 | muscle structure development (GO:0061061) | 3.73140815 |
| 43 | cardiac muscle contraction (GO:0060048) | 3.63476592 |
| 44 | striated muscle adaptation (GO:0014888) | 3.63003791 |
| 45 | adult heart development (GO:0007512) | 3.59609456 |
| 46 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.58601587 |
| 47 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.58373564 |
| 48 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.56095289 |
| 49 | response to caffeine (GO:0031000) | 3.54789008 |
| 50 | muscle tissue morphogenesis (GO:0060415) | 3.52900145 |
| 51 | positive regulation of protein depolymerization (GO:1901881) | 3.51854359 |
| 52 | muscle atrophy (GO:0014889) | 3.51686307 |
| 53 | muscle hypertrophy (GO:0014896) | 3.51319279 |
| 54 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.50902937 |
| 55 | negative regulation of muscle hypertrophy (GO:0014741) | 3.49324753 |
| 56 | regulation of myoblast differentiation (GO:0045661) | 3.48161839 |
| 57 | striated muscle tissue development (GO:0014706) | 3.47255216 |
| 58 | positive regulation of glycogen biosynthetic process (GO:0045725) | 3.46812562 |
| 59 | negative regulation of ion transmembrane transporter activity (GO:0032413) | 3.44741968 |
| 60 | positive regulation of myotube differentiation (GO:0010831) | 3.44658001 |
| 61 | myoblast fusion (GO:0007520) | 3.41905151 |
| 62 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.39699189 |
| 63 | regulation of membrane repolarization (GO:0060306) | 3.37758987 |
| 64 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.37309415 |
| 65 | carnitine shuttle (GO:0006853) | 3.37298617 |
| 66 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.37124150 |
| 67 | cellular response to dexamethasone stimulus (GO:0071549) | 3.35208805 |
| 68 | negative regulation of potassium ion transport (GO:0043267) | 3.34578271 |
| 69 | nucleus localization (GO:0051647) | 3.33926583 |
| 70 | ubiquinone biosynthetic process (GO:0006744) | 3.33537430 |
| 71 | myotube differentiation (GO:0014902) | 3.33108945 |
| 72 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.32581092 |
| 73 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.31304491 |
| 74 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.30016169 |
| 75 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 3.29127939 |
| 76 | muscle cell development (GO:0055001) | 3.27285074 |
| 77 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.22156970 |
| 78 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.21506567 |
| 79 | extracellular regulation of signal transduction (GO:1900115) | 3.20472206 |
| 80 | extracellular negative regulation of signal transduction (GO:1900116) | 3.20472206 |
| 81 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.20088356 |
| 82 | regulation of muscle system process (GO:0090257) | 3.19320441 |
| 83 | response to dexamethasone (GO:0071548) | 3.18150487 |
| 84 | glycogen biosynthetic process (GO:0005978) | 3.17677509 |
| 85 | glucan biosynthetic process (GO:0009250) | 3.17677509 |
| 86 | negative regulation of norepinephrine secretion (GO:0010700) | 3.16325143 |
| 87 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.16158034 |
| 88 | fatty acid transmembrane transport (GO:1902001) | 3.12654359 |
| 89 | negative regulation of cell size (GO:0045792) | 3.11994704 |
| 90 | regulation of the force of heart contraction (GO:0002026) | 3.11051355 |
| 91 | negative regulation of heart growth (GO:0061117) | 3.10701332 |
| 92 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 3.10701332 |
| 93 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.08266627 |
| 94 | extracellular fibril organization (GO:0043206) | 3.06897475 |
| 95 | regulation of fatty acid oxidation (GO:0046320) | 3.06684593 |
| 96 | cardiac muscle cell development (GO:0055013) | 3.06022718 |
| 97 | striated muscle cell development (GO:0055002) | 3.05928044 |
| 98 | regulation of p38MAPK cascade (GO:1900744) | 3.05862960 |
| 99 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.05459628 |
| 100 | glycogen catabolic process (GO:0005980) | 3.04437664 |
| 101 | regulation of muscle contraction (GO:0006937) | 3.02735530 |
| 102 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.02222304 |
| 103 | skeletal muscle tissue development (GO:0007519) | 3.01694036 |
| 104 | muscle tissue development (GO:0060537) | 3.01366317 |
| 105 | negative regulation of calcium ion transport (GO:0051926) | 3.01162358 |
| 106 | positive regulation of striated muscle cell differentiation (GO:0051155) | 2.99958993 |
| 107 | regulation of sequestering of triglyceride (GO:0010889) | 2.98227315 |
| 108 | ubiquinone metabolic process (GO:0006743) | 2.96312207 |
| 109 | regulation of skeletal muscle fiber development (GO:0048742) | 2.96187240 |
| 110 | positive regulation of glomerulus development (GO:0090193) | 2.95412247 |
| 111 | response to inactivity (GO:0014854) | 2.94691195 |
| 112 | regulation of ATP catabolic process (GO:1903289) | 2.93296087 |
| 113 | regulation of ATPase activity (GO:0043462) | 2.93296087 |
| 114 | positive regulation of glycogen metabolic process (GO:0070875) | 2.92704427 |
| 115 | striated muscle atrophy (GO:0014891) | 2.91616460 |
| 116 | regulation of muscle hypertrophy (GO:0014743) | 2.90661188 |
| 117 | behavioral response to nicotine (GO:0035095) | 2.89859974 |
| 118 | cardiac muscle hypertrophy (GO:0003300) | 2.89546303 |
| 119 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.88874845 |
| 120 | neurotransmitter catabolic process (GO:0042135) | 2.87791969 |
| 121 | regulation of striated muscle contraction (GO:0006942) | 2.87314401 |
| 122 | cardiac cell development (GO:0055006) | 2.87089034 |
| 123 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.86617106 |
| 124 | regulation of cardiac muscle cell differentiation (GO:2000725) | 2.86572183 |
| 125 | syncytium formation (GO:0006949) | 2.85424615 |
| 126 | glucan catabolic process (GO:0009251) | 2.84101073 |
| 127 | muscle organ morphogenesis (GO:0048644) | 2.80104025 |
| 128 | striated muscle hypertrophy (GO:0014897) | 2.79734064 |
| 129 | positive regulation of cation channel activity (GO:2001259) | 2.78000981 |
| 130 | muscle adaptation (GO:0043500) | 2.77683243 |
| 131 | positive regulation of skeletal muscle tissue development (GO:0048643) | 2.77371115 |
| 132 | actin-myosin filament sliding (GO:0033275) | 15.2988299 |
| 133 | muscle filament sliding (GO:0030049) | 15.2988299 |
| 134 | skeletal muscle contraction (GO:0003009) | 12.7534708 |
| 135 | actin-mediated cell contraction (GO:0070252) | 12.6744293 |
| 136 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.6471913 |
| 137 | regulation of relaxation of muscle (GO:1901077) | 10.0709469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.96357304 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.85902484 |
| 3 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.23144368 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.07185609 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.04589074 |
| 6 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.57267934 |
| 7 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.56630182 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.44200836 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.40808696 |
| 10 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.15282155 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.11952800 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.11492157 |
| 13 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.04549562 |
| 14 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.99659293 |
| 15 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.99373993 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.98176421 |
| 17 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.96974548 |
| 18 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.92548320 |
| 19 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.81132005 |
| 20 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.77073004 |
| 21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.77073004 |
| 22 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.75407273 |
| 23 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.75407273 |
| 24 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.73062170 |
| 25 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.73039093 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.70706480 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.68644303 |
| 28 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.58105016 |
| 29 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.57604534 |
| 30 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.55839516 |
| 31 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.55081113 |
| 32 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.50927763 |
| 33 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.48399701 |
| 34 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.46870216 |
| 35 | CJUN_26792858_Chip-Seq_BT549_Human | 1.45940858 |
| 36 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.45896219 |
| 37 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.43953340 |
| 38 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.42805983 |
| 39 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42669521 |
| 40 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.42033171 |
| 41 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.41330044 |
| 42 | FUS_26573619_Chip-Seq_HEK293_Human | 1.39528091 |
| 43 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.37344238 |
| 44 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.36529605 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36051924 |
| 46 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.35496484 |
| 47 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.33094069 |
| 48 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.32610202 |
| 49 | TP53_16413492_ChIP-PET_HCT116_Human | 1.30668751 |
| 50 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.30256168 |
| 51 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.30256168 |
| 52 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.30145233 |
| 53 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.28796101 |
| 54 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.27452882 |
| 55 | P300_19829295_ChIP-Seq_ESCs_Human | 1.27345607 |
| 56 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.27048479 |
| 57 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.27048479 |
| 58 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.26478399 |
| 59 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.26292553 |
| 60 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.26264381 |
| 61 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.26142858 |
| 62 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.25887779 |
| 63 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25763390 |
| 64 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25655357 |
| 65 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.24462923 |
| 66 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.23465964 |
| 67 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.21853281 |
| 68 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21286986 |
| 69 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.20674103 |
| 70 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.20561534 |
| 71 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.20164579 |
| 72 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.20139027 |
| 73 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.19946733 |
| 74 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.18294059 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18174658 |
| 76 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.17405475 |
| 77 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.16913119 |
| 78 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.15734814 |
| 79 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.15497606 |
| 80 | TCF4_23295773_ChIP-Seq_U87_Human | 1.15300662 |
| 81 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.14660169 |
| 82 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13907338 |
| 83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13590871 |
| 84 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.13562904 |
| 85 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.12271624 |
| 86 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.11823445 |
| 87 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.11311243 |
| 88 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.10990275 |
| 89 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.10533444 |
| 90 | AR_19668381_ChIP-Seq_PC3_Human | 1.10063754 |
| 91 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.09235029 |
| 92 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.09235029 |
| 93 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09003219 |
| 94 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.08140315 |
| 95 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.07766529 |
| 96 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07473425 |
| 97 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.07021025 |
| 98 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.06941880 |
| 99 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.06507515 |
| 100 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.06438271 |
| 101 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.05985730 |
| 102 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05338532 |
| 103 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04909610 |
| 104 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.04203261 |
| 105 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.03561546 |
| 106 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03051928 |
| 107 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.02167077 |
| 108 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.02082465 |
| 109 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.01983412 |
| 110 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01325783 |
| 111 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.01044968 |
| 112 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.99980692 |
| 113 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.99918841 |
| 114 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.99648037 |
| 115 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99551506 |
| 116 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98955684 |
| 117 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.98915620 |
| 118 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97159000 |
| 119 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.96720142 |
| 120 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95985817 |
| 121 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95531167 |
| 122 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.95309740 |
| 123 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.95298563 |
| 124 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.94426194 |
| 125 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.93664040 |
| 126 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93162636 |
| 127 | AR_25329375_ChIP-Seq_VCAP_Human | 0.92943309 |
| 128 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.92928641 |
| 129 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.91935243 |
| 130 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.90324068 |
| 131 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.89861342 |
| 132 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89691130 |
| 133 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.89170849 |
| 134 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88727230 |
| 135 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.88249948 |
| 136 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87342186 |
| 137 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.87098772 |
| 138 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.86780935 |
| 139 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.86040142 |
| 140 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.85929702 |
| 141 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.85822673 |
| 142 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.85257719 |
| 143 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.84328605 |
| 144 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84328605 |
| 145 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83502829 |
| 146 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.83182798 |
| 147 | KDM2B_26808549_Chip-Seq_REH_Human | 0.82634687 |
| 148 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.81594384 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 6.51333387 |
| 2 | MP0000749_muscle_degeneration | 5.93168998 |
| 3 | MP0000751_myopathy | 5.51143727 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 4.53596005 |
| 5 | MP0000747_muscle_weakness | 4.16387270 |
| 6 | MP0005275_abnormal_skin_tensile | 3.56452736 |
| 7 | MP0003950_abnormal_plasma_membrane | 3.48708300 |
| 8 | MP0002106_abnormal_muscle_physiology | 3.34042893 |
| 9 | MP0004087_abnormal_muscle_fiber | 3.32913890 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 3.25520824 |
| 11 | MP0004272_abnormal_basement_membrane | 3.04086388 |
| 12 | MP0000759_abnormal_skeletal_muscle | 2.95759672 |
| 13 | MP0005369_muscle_phenotype | 2.86569702 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.80751813 |
| 15 | MP0002269_muscular_atrophy | 2.79361708 |
| 16 | MP0004036_abnormal_muscle_relaxation | 2.73000673 |
| 17 | MP0000733_abnormal_muscle_development | 2.65903052 |
| 18 | MP0004484_altered_response_of | 2.63247080 |
| 19 | MP0004264_abnormal_extraembryonic_tissu | 2.53999573 |
| 20 | MP0004510_myositis | 2.53368404 |
| 21 | MP0000750_abnormal_muscle_regeneration | 2.49969765 |
| 22 | MP0005503_abnormal_tendon_morphology | 2.43404623 |
| 23 | MP0004130_abnormal_muscle_cell | 2.38632406 |
| 24 | MP0005330_cardiomyopathy | 2.36559671 |
| 25 | MP0002108_abnormal_muscle_morphology | 2.33957128 |
| 26 | MP0003122_maternal_imprinting | 2.08204455 |
| 27 | MP0003646_muscle_fatigue | 2.01672282 |
| 28 | MP0004084_abnormal_cardiac_muscle | 1.93852486 |
| 29 | MP0004215_abnormal_myocardial_fiber | 1.87334839 |
| 30 | MP0003045_fibrosis | 1.85301086 |
| 31 | MP0002972_abnormal_cardiac_muscle | 1.70529616 |
| 32 | MP0004233_abnormal_muscle_weight | 1.48027412 |
| 33 | MP0010630_abnormal_cardiac_muscle | 1.43751788 |
| 34 | MP0004270_analgesia | 1.42549550 |
| 35 | MP0008775_abnormal_heart_ventricle | 1.22264034 |
| 36 | MP0002332_abnormal_exercise_endurance | 1.21902448 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.21238391 |
| 38 | MP0006276_abnormal_autonomic_nervous | 1.19480547 |
| 39 | MP0002089_abnormal_postnatal_growth/wei | 1.19023152 |
| 40 | MP0009384_cardiac_valve_regurgitation | 1.12654162 |
| 41 | MP0002127_abnormal_cardiovascular_syste | 1.11583432 |
| 42 | MP0000372_irregular_coat_pigmentation | 1.09453154 |
| 43 | MP0004134_abnormal_chest_morphology | 1.09216167 |
| 44 | MP0004147_increased_porphyrin_level | 1.05978738 |
| 45 | MP0003123_paternal_imprinting | 1.03148815 |
| 46 | MP0001299_abnormal_eye_distance/ | 1.01112273 |
| 47 | MP0002971_abnormal_brown_adipose | 0.98459047 |
| 48 | MP0003121_genomic_imprinting | 0.91139101 |
| 49 | MP0000013_abnormal_adipose_tissue | 0.87314453 |
| 50 | MP0005623_abnormal_meninges_morphology | 0.87023035 |
| 51 | MP0001958_emphysema | 0.81832921 |
| 52 | MP0002166_altered_tumor_susceptibility | 0.80651573 |
| 53 | MP0001661_extended_life_span | 0.80294093 |
| 54 | MP0002896_abnormal_bone_mineralization | 0.79531374 |
| 55 | MP0003137_abnormal_impulse_conducting | 0.77238778 |
| 56 | MP0005076_abnormal_cell_differentiation | 0.76395865 |
| 57 | MP0002876_abnormal_thyroid_physiology | 0.76188153 |
| 58 | MP0005645_abnormal_hypothalamus_physiol | 0.74813928 |
| 59 | MP0003279_aneurysm | 0.74180802 |
| 60 | MP0002102_abnormal_ear_morphology | 0.73700364 |
| 61 | MP0003136_yellow_coat_color | 0.73674694 |
| 62 | MP0002638_abnormal_pupillary_reflex | 0.73215006 |
| 63 | MP0005385_cardiovascular_system_phenoty | 0.72596160 |
| 64 | MP0001544_abnormal_cardiovascular_syste | 0.72596160 |
| 65 | MP0004197_abnormal_fetal_growth/weight/ | 0.72406742 |
| 66 | MP0009250_abnormal_appendicular_skeleto | 0.70343469 |
| 67 | MP0003879_abnormal_hair_cell | 0.70042162 |
| 68 | MP0002168_other_aberrant_phenotype | 0.68992309 |
| 69 | MP0003941_abnormal_skin_development | 0.67375903 |
| 70 | MP0002734_abnormal_mechanical_nocicepti | 0.67245684 |
| 71 | MP0002006_tumorigenesis | 0.66529333 |
| 72 | MP0005334_abnormal_fat_pad | 0.66258180 |
| 73 | MP0002163_abnormal_gland_morphology | 0.65548756 |
| 74 | MP0000343_altered_response_to | 0.65391499 |
| 75 | MP0004185_abnormal_adipocyte_glucose | 0.64811963 |
| 76 | MP0005666_abnormal_adipose_tissue | 0.64384547 |
| 77 | MP0000767_abnormal_smooth_muscle | 0.64039355 |
| 78 | MP0002249_abnormal_larynx_morphology | 0.63331544 |
| 79 | MP0005166_decreased_susceptibility_to | 0.62195028 |
| 80 | MP0002060_abnormal_skin_morphology | 0.61306304 |
| 81 | MP0002234_abnormal_pharynx_morphology | 0.61282587 |
| 82 | MP0001986_abnormal_taste_sensitivity | 0.61067834 |
| 83 | MP0005451_abnormal_body_composition | 0.60853132 |
| 84 | MP0006292_abnormal_olfactory_placode | 0.60602921 |
| 85 | MP0004043_abnormal_pH_regulation | 0.58460074 |
| 86 | MP0003385_abnormal_body_wall | 0.57504671 |
| 87 | MP0008569_lethality_at_weaning | 0.56118410 |
| 88 | MP0000266_abnormal_heart_morphology | 0.55490710 |
| 89 | MP0010030_abnormal_orbit_morphology | 0.55441152 |
| 90 | MP0005595_abnormal_vascular_smooth | 0.54750831 |
| 91 | MP0003252_abnormal_bile_duct | 0.54314056 |
| 92 | MP0004885_abnormal_endolymph | 0.53342664 |
| 93 | MP0005375_adipose_tissue_phenotype | 0.52873503 |
| 94 | MP0002138_abnormal_hepatobiliary_system | 0.52773436 |
| 95 | MP0005551_abnormal_eye_electrophysiolog | 0.52028358 |
| 96 | MP0006036_abnormal_mitochondrial_physio | 0.51078651 |
| 97 | MP0002114_abnormal_axial_skeleton | 0.49707807 |
| 98 | MP0003567_abnormal_fetal_cardiomyocyte | 0.48968938 |
| 99 | MP0000462_abnormal_digestive_system | 0.48461102 |
| 100 | MP0005171_absent_coat_pigmentation | 0.47910932 |
| 101 | MP0009115_abnormal_fat_cell | 0.47773493 |
| 102 | MP0009780_abnormal_chondrocyte_physiolo | 0.47073738 |
| 103 | MP0004142_abnormal_muscle_tone | 0.46717289 |
| 104 | MP0001485_abnormal_pinna_reflex | 0.45862146 |
| 105 | MP0004883_abnormal_blood_vessel | 0.45741553 |
| 106 | MP0005508_abnormal_skeleton_morphology | 0.44863098 |
| 107 | MP0000003_abnormal_adipose_tissue | 0.44701797 |
| 108 | MP0010368_abnormal_lymphatic_system | 0.44565570 |
| 109 | MP0002822_catalepsy | 0.44435302 |
| 110 | MP0003787_abnormal_imprinting | 0.44215234 |
| 111 | MP0002067_abnormal_sensory_capabilities | 0.43087124 |
| 112 | MP0003221_abnormal_cardiomyocyte_apopto | 0.42883778 |
| 113 | MP0001984_abnormal_olfaction | 0.42861810 |
| 114 | MP0004085_abnormal_heartbeat | 0.42492595 |
| 115 | MP0005670_abnormal_white_adipose | 0.41997836 |
| 116 | MP0001486_abnormal_startle_reflex | 0.41394824 |
| 117 | MP0003195_calcinosis | 0.41374676 |
| 118 | MP0006072_abnormal_retinal_apoptosis | 0.40845418 |
| 119 | MP0005423_abnormal_somatic_nervous | 0.40522239 |
| 120 | MP0002128_abnormal_blood_circulation | 0.40364267 |
| 121 | MP0003283_abnormal_digestive_organ | 0.39838106 |
| 122 | MP0005253_abnormal_eye_physiology | 0.38972482 |
| 123 | MP0005167_abnormal_blood-brain_barrier | 0.38145486 |
| 124 | MP0002078_abnormal_glucose_homeostasis | 0.36158793 |
| 125 | MP0001529_abnormal_vocalization | 0.35879612 |
| 126 | MP0005646_abnormal_pituitary_gland | 0.35874452 |
| 127 | MP0006138_congestive_heart_failure | 0.35704249 |
| 128 | MP0008961_abnormal_basal_metabolism | 0.35275747 |
| 129 | MP0002272_abnormal_nervous_system | 0.35185039 |
| 130 | MP0003638_abnormal_response/metabolism_ | 0.35178572 |
| 131 | MP0003948_abnormal_gas_homeostasis | 0.35115815 |
| 132 | MP0005452_abnormal_adipose_tissue | 0.34707873 |
| 133 | MP0005379_endocrine/exocrine_gland_phen | 0.34430089 |
| 134 | MP0002184_abnormal_innervation | 0.33991504 |
| 135 | MP0005083_abnormal_biliary_tract | 0.33987038 |
| 136 | MP0000534_abnormal_ureter_morphology | 0.33689435 |
| 137 | MP0005266_abnormal_metabolism | 0.33574835 |
| 138 | MP0000230_abnormal_systemic_arterial | 0.32455691 |
| 139 | MP0003566_abnormal_cell_adhesion | 0.32428421 |
| 140 | MP0008770_decreased_survivor_rate | 0.29541453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 9.74980428 |
| 2 | Neoplasm of the heart (HP:0100544) | 6.49973792 |
| 3 | Round ear (HP:0100830) | 6.44268708 |
| 4 | Myopathic facies (HP:0002058) | 6.32919456 |
| 5 | Slender build (HP:0001533) | 5.98128396 |
| 6 | Ulnar deviation of the wrist (HP:0003049) | 5.69954755 |
| 7 | Trismus (HP:0000211) | 5.30022150 |
| 8 | Calcaneovalgus deformity (HP:0001848) | 5.25405790 |
| 9 | Exercise-induced myalgia (HP:0003738) | 5.14926759 |
| 10 | Muscle fiber splitting (HP:0003555) | 5.10191715 |
| 11 | Calf muscle hypertrophy (HP:0008981) | 4.93404648 |
| 12 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.78459254 |
| 13 | Deformed tarsal bones (HP:0008119) | 4.66156670 |
| 14 | Neck muscle weakness (HP:0000467) | 4.64553436 |
| 15 | Frequent falls (HP:0002359) | 4.60548083 |
| 16 | Metatarsus adductus (HP:0001840) | 4.57232300 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 4.56983478 |
| 18 | Absent phalangeal crease (HP:0006109) | 4.33171135 |
| 19 | Exercise-induced muscle cramps (HP:0003710) | 4.32026652 |
| 20 | Mildly elevated creatine phosphokinase (HP:0008180) | 4.26822762 |
| 21 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 4.02517774 |
| 22 | Abnormality of the calf musculature (HP:0001430) | 4.01550679 |
| 23 | Spinal rigidity (HP:0003306) | 3.93833374 |
| 24 | Increased connective tissue (HP:0009025) | 3.85145586 |
| 25 | Abnormal finger flexion creases (HP:0006143) | 3.62340160 |
| 26 | Rimmed vacuoles (HP:0003805) | 3.58379905 |
| 27 | Hyporeflexia of lower limbs (HP:0002600) | 3.43894299 |
| 28 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.43474938 |
| 29 | Popliteal pterygium (HP:0009756) | 3.42448056 |
| 30 | Sudden death (HP:0001699) | 3.34112075 |
| 31 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.26555740 |
| 32 | Abnormality of the calcaneus (HP:0008364) | 3.24198109 |
| 33 | Increased variability in muscle fiber diameter (HP:0003557) | 3.03416555 |
| 34 | EMG: neuropathic changes (HP:0003445) | 2.93079197 |
| 35 | Generalized muscle weakness (HP:0003324) | 2.75784900 |
| 36 | Fatigable weakness (HP:0003473) | 2.68518942 |
| 37 | Abnormality of the neuromuscular junction (HP:0003398) | 2.68518942 |
| 38 | Bulbar palsy (HP:0001283) | 2.64841890 |
| 39 | Ulnar deviation of finger (HP:0009465) | 2.59865103 |
| 40 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.56423579 |
| 41 | Subaortic stenosis (HP:0001682) | 2.56423579 |
| 42 | Bundle branch block (HP:0011710) | 2.56168614 |
| 43 | Deep philtrum (HP:0002002) | 2.55959101 |
| 44 | Difficulty running (HP:0009046) | 2.55638083 |
| 45 | Type 2 muscle fiber atrophy (HP:0003554) | 2.52836307 |
| 46 | Muscle stiffness (HP:0003552) | 2.46550394 |
| 47 | Cutaneous syndactyly (HP:0012725) | 2.42734456 |
| 48 | Hip contracture (HP:0003273) | 2.42515515 |
| 49 | Amniotic constriction ring (HP:0009775) | 2.39638069 |
| 50 | Abnormality of placental membranes (HP:0011409) | 2.39638069 |
| 51 | Hammertoe (HP:0001765) | 2.38102520 |
| 52 | Aplasia of the musculature (HP:0100854) | 2.36696148 |
| 53 | Ventricular tachycardia (HP:0004756) | 2.36454783 |
| 54 | Myotonia (HP:0002486) | 2.32343527 |
| 55 | Asymmetric septal hypertrophy (HP:0001670) | 2.25568686 |
| 56 | Hyperkalemia (HP:0002153) | 2.20579519 |
| 57 | Myoglobinuria (HP:0002913) | 2.15944277 |
| 58 | Muscle fiber atrophy (HP:0100295) | 2.12038880 |
| 59 | Waddling gait (HP:0002515) | 2.11395695 |
| 60 | Scapular winging (HP:0003691) | 2.11310166 |
| 61 | Gowers sign (HP:0003391) | 2.00608880 |
| 62 | Distal arthrogryposis (HP:0005684) | 14.4395444 |
| 63 | Nemaline bodies (HP:0003798) | 10.2435012 |
| 64 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 10.0772062 |
| 65 | Type 1 muscle fiber predominance (HP:0003803) | 10.0230209 |
| 66 | Adducted thumb (HP:0001181) | 1.97749055 |
| 67 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.96894048 |
| 68 | Distal lower limb muscle weakness (HP:0009053) | 1.93581592 |
| 69 | Fetal akinesia sequence (HP:0001989) | 1.91404112 |
| 70 | Limb-girdle muscle atrophy (HP:0003797) | 1.86853621 |
| 71 | Breech presentation (HP:0001623) | 1.83602136 |
| 72 | Rhabdomyolysis (HP:0003201) | 1.81244590 |
| 73 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.79857477 |
| 74 | Muscular dystrophy (HP:0003560) | 1.78359764 |
| 75 | Limited hip movement (HP:0008800) | 1.74883679 |
| 76 | Facial diplegia (HP:0001349) | 1.74032550 |
| 77 | Akinesia (HP:0002304) | 1.73649083 |
| 78 | Malignant hyperthermia (HP:0002047) | 1.71270581 |
| 79 | Nonprogressive disorder (HP:0003680) | 1.69681742 |
| 80 | Diaphragmatic weakness (HP:0009113) | 1.66615605 |
| 81 | Heart block (HP:0012722) | 1.64016566 |
| 82 | Tarsal synostosis (HP:0008368) | 1.62447396 |
| 83 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.60493234 |
| 84 | Type II lissencephaly (HP:0007260) | 1.59034647 |
| 85 | Rocker bottom foot (HP:0001838) | 1.56417336 |
| 86 | Hypoplastic ischia (HP:0003175) | 1.55794544 |
| 87 | Areflexia of lower limbs (HP:0002522) | 1.55485337 |
| 88 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.55319284 |
| 89 | Atrial fibrillation (HP:0005110) | 1.55312121 |
| 90 | Broad metatarsal (HP:0001783) | 1.54634769 |
| 91 | Proximal amyotrophy (HP:0007126) | 1.52545085 |
| 92 | Left ventricular hypertrophy (HP:0001712) | 1.52082731 |
| 93 | Foot dorsiflexor weakness (HP:0009027) | 1.51954541 |
| 94 | Limb-girdle muscle weakness (HP:0003325) | 1.51939794 |
| 95 | Difficulty climbing stairs (HP:0003551) | 1.51581099 |
| 96 | Ankle contracture (HP:0006466) | 1.51462996 |
| 97 | Steppage gait (HP:0003376) | 1.51217225 |
| 98 | Cerebral aneurysm (HP:0004944) | 1.48583312 |
| 99 | Synostosis involving bones of the feet (HP:0009140) | 1.47350055 |
| 100 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.47350055 |
| 101 | Abnormal atrioventricular conduction (HP:0005150) | 1.47146495 |
| 102 | Distal lower limb amyotrophy (HP:0008944) | 1.47117365 |
| 103 | Webbed neck (HP:0000465) | 1.46056024 |
| 104 | Lipoatrophy (HP:0100578) | 1.44394632 |
| 105 | Cerebellar dysplasia (HP:0007033) | 1.43965686 |
| 106 | Abnormality of the foot musculature (HP:0001436) | 1.43745884 |
| 107 | Protrusio acetabuli (HP:0003179) | 1.43605229 |
| 108 | Primary atrial arrhythmia (HP:0001692) | 1.42930416 |
| 109 | Abnormality of the ischium (HP:0003174) | 1.41874229 |
| 110 | Pelvic girdle muscle weakness (HP:0003749) | 1.40501400 |
| 111 | Mitral valve prolapse (HP:0001634) | 1.39617892 |
| 112 | Striae distensae (HP:0001065) | 1.38870093 |
| 113 | Shoulder girdle muscle weakness (HP:0003547) | 1.36531817 |
| 114 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.34899445 |
| 115 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.34899445 |
| 116 | Weak cry (HP:0001612) | 1.33642483 |
| 117 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.33563071 |
| 118 | Lower limb amyotrophy (HP:0007210) | 1.32390396 |
| 119 | Dilated cardiomyopathy (HP:0001644) | 1.32019766 |
| 120 | Achilles tendon contracture (HP:0001771) | 1.30238805 |
| 121 | Congenital hip dislocation (HP:0001374) | 1.26667839 |
| 122 | Progressive muscle weakness (HP:0003323) | 1.26406484 |
| 123 | Long clavicles (HP:0000890) | 1.24117928 |
| 124 | Abnormality of the Achilles tendon (HP:0005109) | 1.21428192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CG | 4.96539458 |
| 2 | SIK1 | 4.05952504 |
| 3 | TTN | 2.84509650 |
| 4 | PHKG1 | 2.25478712 |
| 5 | PHKG2 | 2.25478712 |
| 6 | DMPK | 2.17060967 |
| 7 | OBSCN | 13.2081170 |
| 8 | MUSK | 1.91289507 |
| 9 | NME1 | 1.80547559 |
| 10 | FRK | 1.77581917 |
| 11 | PIK3CA | 1.38762407 |
| 12 | CCNB1 | 1.36625284 |
| 13 | MARK1 | 1.29178305 |
| 14 | MAP4K2 | 1.28793766 |
| 15 | INSRR | 1.22704263 |
| 16 | CSF1R | 1.22328904 |
| 17 | ADRBK2 | 1.18324019 |
| 18 | MAP3K7 | 1.15383362 |
| 19 | EIF2AK2 | 1.14015198 |
| 20 | BMPR1B | 1.13967493 |
| 21 | ZAK | 1.06754008 |
| 22 | TRIB3 | 0.98635460 |
| 23 | RIPK1 | 0.98442529 |
| 24 | JAK1 | 0.96404862 |
| 25 | EPHB1 | 0.95583038 |
| 26 | MOS | 0.93557668 |
| 27 | MAPK12 | 0.91298062 |
| 28 | ERBB3 | 0.90036195 |
| 29 | MAP2K6 | 0.84219255 |
| 30 | NEK1 | 0.83402439 |
| 31 | WNK4 | 0.75990820 |
| 32 | ROCK1 | 0.75585896 |
| 33 | PKN2 | 0.75150522 |
| 34 | PDGFRA | 0.74867084 |
| 35 | PDK3 | 0.73639055 |
| 36 | PDK4 | 0.73639055 |
| 37 | MAPK7 | 0.70130808 |
| 38 | MAPKAPK3 | 0.69529463 |
| 39 | ROCK2 | 0.69185507 |
| 40 | BCKDK | 0.68981663 |
| 41 | MARK3 | 0.66570275 |
| 42 | STK11 | 0.65556847 |
| 43 | TGFBR2 | 0.64667527 |
| 44 | TNIK | 0.64303126 |
| 45 | TIE1 | 0.63873633 |
| 46 | PTK6 | 0.61358676 |
| 47 | NUAK1 | 0.57642675 |
| 48 | MAP2K3 | 0.57513374 |
| 49 | FGFR4 | 0.57357585 |
| 50 | WNK3 | 0.56993692 |
| 51 | TRPM7 | 0.55037921 |
| 52 | MAP2K1 | 0.54767571 |
| 53 | CAMK1 | 0.53445923 |
| 54 | OXSR1 | 0.50826839 |
| 55 | PRKAA1 | 0.48960682 |
| 56 | CAMK2D | 0.48948075 |
| 57 | GRK7 | 0.48858277 |
| 58 | NLK | 0.48248154 |
| 59 | CAMK4 | 0.48118174 |
| 60 | DYRK1B | 0.46588950 |
| 61 | NEK9 | 0.46466932 |
| 62 | MAP2K4 | 0.46150097 |
| 63 | PKN1 | 0.44576818 |
| 64 | PRKG1 | 0.43633423 |
| 65 | TLK1 | 0.43566692 |
| 66 | PRKCQ | 0.43150066 |
| 67 | PINK1 | 0.42423292 |
| 68 | MAP3K4 | 0.42290778 |
| 69 | DDR2 | 0.41938072 |
| 70 | TAOK3 | 0.41806446 |
| 71 | PRKAA2 | 0.41419141 |
| 72 | TXK | 0.40797303 |
| 73 | LIMK1 | 0.39401161 |
| 74 | STK39 | 0.39047693 |
| 75 | SGK1 | 0.38517283 |
| 76 | AKT2 | 0.38270682 |
| 77 | CAMK2G | 0.36334330 |
| 78 | TYK2 | 0.36241936 |
| 79 | NTRK3 | 0.36154840 |
| 80 | LATS1 | 0.36034830 |
| 81 | STK38L | 0.34724312 |
| 82 | PRKCH | 0.34388993 |
| 83 | TGFBR1 | 0.34304452 |
| 84 | MAPKAPK5 | 0.34207241 |
| 85 | RPS6KB1 | 0.33389632 |
| 86 | CASK | 0.32928347 |
| 87 | RET | 0.32553767 |
| 88 | PDK2 | 0.32271434 |
| 89 | GRK1 | 0.31957318 |
| 90 | MTOR | 0.30940169 |
| 91 | KIT | 0.30914695 |
| 92 | CAMK1G | 0.30878766 |
| 93 | MAPK11 | 0.29844853 |
| 94 | CSNK1G1 | 0.29841177 |
| 95 | PDPK1 | 0.28454503 |
| 96 | PDK1 | 0.28346505 |
| 97 | MAP2K2 | 0.27828869 |
| 98 | ADRBK1 | 0.27055184 |
| 99 | EEF2K | 0.26793027 |
| 100 | FGFR3 | 0.26767914 |
| 101 | IKBKB | 0.26674094 |
| 102 | CAMK1D | 0.26243122 |
| 103 | CHUK | 0.26137457 |
| 104 | PDGFRB | 0.25412268 |
| 105 | CSNK1G2 | 0.25262156 |
| 106 | RPS6KB2 | 0.24817208 |
| 107 | MAPK13 | 0.24707459 |
| 108 | MAP3K10 | 0.24209991 |
| 109 | CDK19 | 0.23715986 |
| 110 | CAMK2A | 0.23492853 |
| 111 | PRKD1 | 0.22900537 |
| 112 | CAMK2B | 0.22819850 |
| 113 | EPHA3 | 0.22538424 |
| 114 | STK16 | 0.22126616 |
| 115 | MAP3K13 | 0.21243109 |
| 116 | PRKACB | 0.20810862 |
| 117 | NTRK2 | 0.20802334 |
| 118 | TNK2 | 0.19880235 |
| 119 | ILK | 0.19520099 |
| 120 | PRKCE | 0.19235368 |
| 121 | SGK3 | 0.18401214 |
| 122 | PRKACA | 0.17963694 |
| 123 | PRKCA | 0.17507349 |
| 124 | CSNK1D | 0.16699487 |
| 125 | RPS6KA3 | 0.16133491 |
| 126 | FGFR2 | 0.15661152 |
| 127 | RPS6KA6 | 0.15099464 |
| 128 | SGK2 | 0.15087461 |
| 129 | CSNK1G3 | 0.14600615 |
| 130 | INSR | 0.14564375 |
| 131 | DAPK2 | 0.14478218 |
| 132 | PAK6 | 0.13618430 |
| 133 | ACVR1B | 0.13427334 |
| 134 | WNK1 | 0.13203524 |
| 135 | MST1R | 0.12489954 |
| 136 | HCK | 0.12381552 |
| 137 | IGF1R | 0.12043886 |
| 138 | RPS6KA1 | 0.11640973 |
| 139 | MARK2 | 0.11393399 |
| 140 | MAPK4 | 0.11326082 |
| 141 | PTK2B | 0.10675506 |
| 142 | PRKACG | 0.10671563 |
| 143 | SIK2 | 0.10243956 |
| 144 | MAP3K9 | 0.10079405 |
| 145 | SGK494 | 0.09919639 |
| 146 | SGK223 | 0.09919639 |
| 147 | FYN | 0.09833514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.31538356 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.31287375 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.55054516 |
| 4 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.42203918 |
| 5 | Tight junction_Homo sapiens_hsa04530 | 2.37098544 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 2.34746818 |
| 7 | Circadian rhythm_Homo sapiens_hsa04710 | 2.31924434 |
| 8 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.30664575 |
| 9 | Viral myocarditis_Homo sapiens_hsa05416 | 2.23993947 |
| 10 | Focal adhesion_Homo sapiens_hsa04510 | 2.21340825 |
| 11 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 1.86779985 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.82332588 |
| 13 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.80131635 |
| 14 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.78808451 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.77500186 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.77183168 |
| 17 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.73498276 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.73144592 |
| 19 | Insulin resistance_Homo sapiens_hsa04931 | 1.72501865 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.72302288 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.68414084 |
| 22 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.67036121 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.64427132 |
| 24 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.64308401 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.62633742 |
| 26 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.57545002 |
| 27 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.55403211 |
| 28 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.52492280 |
| 29 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.47785900 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.47486159 |
| 31 | Amoebiasis_Homo sapiens_hsa05146 | 1.42376779 |
| 32 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.41851032 |
| 33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.41227269 |
| 34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.32214884 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.31263803 |
| 36 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.29963735 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.25489896 |
| 38 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.16550020 |
| 39 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.11752914 |
| 40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.11204985 |
| 41 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10251039 |
| 42 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.09662620 |
| 43 | * Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.09122050 |
| 44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08832450 |
| 45 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.01768644 |
| 46 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.99412863 |
| 47 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.98980009 |
| 48 | Renin secretion_Homo sapiens_hsa04924 | 0.98844808 |
| 49 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.98056699 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 0.97819713 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 0.94734675 |
| 52 | * Gastric acid secretion_Homo sapiens_hsa04971 | 0.91283760 |
| 53 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.89061256 |
| 54 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.87755409 |
| 55 | Adherens junction_Homo sapiens_hsa04520 | 0.87201493 |
| 56 | Circadian entrainment_Homo sapiens_hsa04713 | 0.84646228 |
| 57 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.83578745 |
| 58 | Huntingtons disease_Homo sapiens_hsa05016 | 0.83244363 |
| 59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81609556 |
| 60 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.81509065 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80965546 |
| 62 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80805668 |
| 63 | Peroxisome_Homo sapiens_hsa04146 | 0.79714982 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.78661053 |
| 65 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.78277448 |
| 66 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.71611045 |
| 67 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68121619 |
| 68 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.67009629 |
| 69 | * Insulin secretion_Homo sapiens_hsa04911 | 0.66351682 |
| 70 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.66319702 |
| 71 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.64972149 |
| 72 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.64248039 |
| 73 | Olfactory transduction_Homo sapiens_hsa04740 | 0.63954415 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63828100 |
| 75 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63252895 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62719168 |
| 77 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.62378343 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.62348621 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.62085481 |
| 80 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61813641 |
| 81 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.61372502 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58122461 |
| 83 | * Bile secretion_Homo sapiens_hsa04976 | 0.56985728 |
| 84 | * Salivary secretion_Homo sapiens_hsa04970 | 0.55385361 |
| 85 | Long-term depression_Homo sapiens_hsa04730 | 0.55235618 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55076676 |
| 87 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.54867713 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.53427930 |
| 89 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.53105423 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53051664 |
| 91 | Lysine degradation_Homo sapiens_hsa00310 | 0.52944204 |
| 92 | GABAergic synapse_Homo sapiens_hsa04727 | 0.51963271 |
| 93 | Glioma_Homo sapiens_hsa05214 | 0.51528766 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51139549 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.49745518 |
| 96 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.49639550 |
| 97 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.49537217 |
| 98 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49085889 |
| 99 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.48695989 |
| 100 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.48404184 |
| 101 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.47547809 |
| 102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47521913 |
| 103 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46508878 |
| 104 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46203040 |
| 105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44441956 |
| 106 | Taste transduction_Homo sapiens_hsa04742 | 0.44343756 |
| 107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.44058834 |
| 108 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43314641 |
| 109 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.43193139 |
| 110 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.42962003 |
| 111 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.42719635 |
| 112 | RNA degradation_Homo sapiens_hsa03018 | 0.42276759 |
| 113 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.41961230 |
| 114 | Gap junction_Homo sapiens_hsa04540 | 0.40931861 |
| 115 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.37428548 |
| 116 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.37193827 |
| 117 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.36314719 |
| 118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36207219 |
| 119 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.35889638 |
| 120 | Purine metabolism_Homo sapiens_hsa00230 | 0.35090899 |
| 121 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34561247 |
| 122 | Morphine addiction_Homo sapiens_hsa05032 | 0.34099744 |
| 123 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.33954873 |
| 124 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33555426 |
| 125 | Melanogenesis_Homo sapiens_hsa04916 | 0.33182737 |
| 126 | * Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.33093036 |
| 127 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.33047157 |
| 128 | Malaria_Homo sapiens_hsa05144 | 0.32955930 |
| 129 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.32799741 |
| 130 | Axon guidance_Homo sapiens_hsa04360 | 0.32545599 |
| 131 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32189437 |
| 132 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.31899125 |
| 133 | Sulfur relay system_Homo sapiens_hsa04122 | 0.31369575 |
| 134 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30467623 |
| 135 | Basal transcription factors_Homo sapiens_hsa03022 | 0.30228084 |
| 136 | Long-term potentiation_Homo sapiens_hsa04720 | 0.29807241 |
| 137 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.29669483 |
| 138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27024608 |
| 139 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.25975697 |
| 140 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.25703038 |

